Gene Therapy Frees Patient from 29 Years of Haemophilia B Treatment

Published on Spencer Knight via LinkedIn

Elliott Collins, 34, lived with haemophilia B for nearly three decades, relying on frequent injections to prevent life-threatening bleeds. After receiving Hemgenix, a gene therapy that uses AAV to deliver the clotting factor IX gene directly into the liver, Elliott now considers himself cured. He’s no longer tied to a treatment routine and is exploring life with renewed freedom.

The NHS is also making gene therapy more accessible in the UK through a performance-based agreement with CSL Behring. The NHS only pays if the therapy delivers sustained results, making it a model for value-based innovation.

Read the full article via BBC News:

👉 I have £2.6m blood and it has ‘cured’ my haemophilia

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full details, please refer to the original article via the provided link.